News
Molecular Hydrogen on the Path to Modern Medicine
A Global Problem Without a Simple Solution Dementia and neurodegenerative diseases are among the greatest challenges...
The clinical study has been launched
Today in Ostrava, we initiated a clinical trial and enrolled the first patients, marking a key milestone on the path toward the registration of our medical device.
Science That Makes Sense: Molecular Hydrogen as an Investment in Health and the Future
PharmDr. Milan Krajíček is a pharmacist and entrepreneur who has spent his entire life combining rigorous expertise,...
Japanese Professor Shigeo Ohta on Alzheimer’s Dementia: Why We Do What We Do – They Wrote About Us as Well
When I look back today, I see more than 21 years of life devoted to a single idea.The idea that even the smallest...
Authority in the Field of Molecular Hydrogen
On Friday, we welcomed Professor Shigeo Ohta to the Czech Republic — a world-renowned authority in the field of molecular hydrogen and co-founder of H2 Global Group.
Alzheimer’s Dementia and Longevity: H2 Global Group Offers Solutions, Opens an Investment Window, and Targets the Medicine of the Future
Prague, 19 December 2025 (PROTEXT) – Dementia and Alzheimer’s disease are rapidly becoming one of the greatest health,...